VEGFR2 heterogeneity and response to anti-angiogenic low dose metronomic cyclophosphamide treatment
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
VEGFR2 heterogeneity and response to anti-angiogenic low dose metronomic cyclophosphamide treatment ; volume:10 ; number:1 ; day:15 ; month:12 ; year:2010 ; pages:1-11 ; date:12.2010
BMC cancer ; 10, Heft 1 (15.12.2010), 1-11, 12.2010
- Creator
-
Patten, Steven G.
- Contributor
-
Adamcic, Una
Lacombe, Kristen
Minhas, Kanwal
Skowronski, Karolina
Coomber, Brenda L.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-10-683
- URN
-
urn:nbn:de:1111-2016030354606
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Patten, Steven G.
- Adamcic, Una
- Lacombe, Kristen
- Minhas, Kanwal
- Skowronski, Karolina
- Coomber, Brenda L.
- SpringerLink (Online service)
Other Objects (12)
Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies
Anti-angiogenic therapies in brain metastases
Anti-angiogenic alternatives to VEGF blockade
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
Comparison of anti-angiogenic properties of pristine carbon nanoparticles
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Anti-angiogenic effect of high doses of ascorbic acid
AntAngioCOOL: computational detection of anti-angiogenic peptides
Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies
Anti-angiogenic therapies in brain metastases
Anti-angiogenic alternatives to VEGF blockade
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
Comparison of anti-angiogenic properties of pristine carbon nanoparticles
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Anti-angiogenic effect of high doses of ascorbic acid
AntAngioCOOL: computational detection of anti-angiogenic peptides
Differential expression of VEGFR2 protein in HER2 positive primary human breast cancer: potential relevance to anti-angiogenic therapies
Anti-angiogenic therapies in brain metastases
Anti-angiogenic alternatives to VEGF blockade
Future options of anti-angiogenic cancer therapy
Correction: Beyond starving cancer: anti-angiogenic therapy
Characterization of anti-angiogenic therapy response in glioblastoma
Anti-angiogenic therapies for advanced esophago-gastric cancer
Perforated Gastric Ulcer Associated with Anti-Angiogenic Therapy
Comparison of anti-angiogenic properties of pristine carbon nanoparticles
Proteomic analysis predicts anti-angiogenic resistance in recurred glioblastoma
Anti-angiogenic effect of high doses of ascorbic acid